Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Purchase | 2021-12-01 7:32 pm | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 16,000,000 | $1.25 | $20,000,000 | 78,799,315 (Indirect) | View |
| 2021-02-02 Purchase | 2021-02-02 5:32 pm | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 8,360,000 | $1 | $8,360,000 | 32,427,067 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Option Award | 2024-03-20 5:20 pm | 2024-03-18 2029-03-18 | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 5,764,285 | $0 | 9,266,645 (Indirect) | View |
| 2022-12-28 Option Award | 2022-12-29 5:01 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 14,230,418 | $0.8784 | 70,047,204 (Indirect) | View |
| 2022-04-21 Other(A) | 2022-07-07 5:27 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 27,982,529 | $0 | 83,799,315 (Indirect) | View |
| 2022-02-01 Other | 2022-02-01 5:05 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 2,500,000 | $1.25 | 58,316,786 (Indirect) | View |
| 2021-02-10 Option Award | 2021-02-11 5:46 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 1,013,627 | $1 | 62,799,315 (Indirect) | View |
| 2020-03-19 Option Award | 2020-03-23 5:35 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 68,112 | $0 | 53,493,800 (Direct) | View |
| 2020-03-19 Disposition | 2020-03-23 5:35 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 68,112 | $0 | 53,493,800 (Direct) | View |
| 2020-03-23 Exercise | 2020-03-23 5:35 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 29,426,733 | $0 | 53,493,800 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-27 5:10 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 2,460,630 | $1.016 | 25,297,382 (Indirect) | View |
| 2020-02-26 Option Award | 2020-02-27 5:10 pm | 2020-02-26 2024-02-26 | Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 1,230,315 | $0.125 | 25,297,382 (Indirect) | View |
| 2020-01-27 Option Award | 2020-01-29 5:53 pm | N/A 2025-10-31 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,093,750 | $0 | 26,210,289 (Direct) | View |
| 2020-01-27 Option Award | 2020-01-29 5:53 pm | N/A 2026-05-14 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,564,102 | $1 | 26,210,289 (Direct) | View |
| 2020-01-27 Disposition | 2020-01-29 5:53 pm | N/A 2026-05-14 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,564,102 | $1 | 26,210,289 (Direct) | View |
| 2020-01-27 Disposition | 2020-01-29 5:53 pm | N/A 2025-10-31 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,093,750 | $0 | 26,210,289 (Direct) | View |
| 2020-01-29 Exercise | 2020-01-29 5:53 pm | N/A 2025-10-31 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,093,750 | $0 | 26,210,289 (Direct) | View |
| 2020-01-29 Exercise | 2020-01-29 5:53 pm | N/A 2026-05-14 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,564,102 | $1 | 26,210,289 (Direct) | View |
| 2020-01-29 Exercise | 2020-01-29 5:53 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 4,657,852 | $0.232 | 26,210,289 (Direct) | View |
| 2019-12-31 Other | 2019-12-31 5:15 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 1,661 | $0 | 68,112 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:14 pm | N/A 2019-12-24 | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 3,636,364 | $0 | 16,948,585 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-30 5:14 pm | N/A N/A | Outlook Therapeutics Inc. | OTLK | BioLexis Pte Ltd. Pillai Arun Kumar Sukhtian Ghiath M. Director 10% Owner | 2,909,091 | $0.232 | 16,948,585 (Direct) | View |